KMDA

KMDA

USD

Kamada Ltd. Ordinary Shares

$6.950+0.000 (0.000%)

Real-time Price

Healthcare
Drug Manufacturers - Specialty & Generic
Israel

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$6.950

High

$7.090

Low

$6.930

Volume

0.06M

Company Fundamentals

Market Cap

403.0M

Industry

Drug Manufacturers - Specialty & Generic

Country

Israel

Trading Stats

Avg Volume

0.09M

Exchange

NMS

Currency

USD

52-Week Range

Low $4.74Current $6.950High $9.15

Related News

Analyst Upgrades

Benchmark Reiterates Buy on Kamada, Maintains $15 Price Target

Benchmark analyst Robert Wasserman reiterates Kamada with a Buy and maintains $15 price target.

View more
Benchmark Reiterates Buy on Kamada, Maintains $15 Price Target
GlobeNewswire

Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025

REHOVOT, Israel, and HOBOKEN, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA)), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for

View more
Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025
GlobeNewswire

Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for CYTOGAM®

Program Aimed at Generating Key Data in Support of the Benefits of CYTOGAM® in the Management of Cytomegalovirus (CMV) in Solid Organ TransplantationA Total of 10 Studies will be Conducted in Collaboration with

View more
Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for CYTOGAM®